Quidel ROA 2006-2019 | QDEL

Current and historical return on assets (ROA) values for Quidel (QDEL) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets. Quidel ROA for the three months ending December 31, 2019 was 13.28%.
Quidel ROA - Return on Assets Historical Data
Date TTM Net Income Total Assets Return on Assets
2019-12-31 $0.07B $0.91B 8.27%
2019-09-30 $0.07B $0.87B 8.64%
2019-06-30 $0.07B $0.85B 8.23%
2019-03-31 $0.07B $0.91B 7.95%
2018-12-31 $0.07B $0.81B 9.16%
2018-09-30 $0.04B $0.79B 4.41%
2018-06-30 $0.02B $0.76B 2.69%
2018-03-31 $0.01B $0.87B 1.68%
2017-12-31 $-0.01B $0.94B -1.67%
2017-09-30 $-0.01B $0.41B -1.50%
2017-06-30 $-0.00B $0.40B -0.26%
2017-03-31 $0.00B $0.40B 0.78%
2016-12-31 $-0.01B $0.39B -3.70%
2016-09-30 $-0.01B $0.38B -3.13%
2016-06-30 $-0.01B $0.37B -3.05%
2016-03-31 $-0.01B $0.38B -3.18%
2015-12-31 $-0.01B $0.41B -1.40%
2015-09-30 $0.00B $0.42B 0.23%
2015-06-30 $-0.00B $0.43B -1.00%
2015-03-31 $-0.00B $0.46B -0.56%
2014-12-31 $-0.01B $0.45B -2.57%
2014-09-30 $-0.01B $0.27B -5.24%
2014-06-30 $-0.01B $0.26B -4.50%
2014-03-31 $-0.01B $0.27B -2.61%
2013-12-31 $0.01B $0.27B 2.64%
2013-09-30 $0.02B $0.27B 5.83%
2013-06-30 $0.02B $0.27B 7.19%
2013-03-31 $0.02B $0.26B 7.02%
2012-12-31 $0.01B $0.24B 2.11%
2012-09-30 $-0.00B $0.24B -1.22%
2012-06-30 $-0.00B $0.23B -1.17%
2012-03-31 $-0.00B $0.24B -1.53%
2011-12-31 $0.01B $0.28B 2.62%
2011-09-30 $0.01B $0.27B 2.39%
2011-06-30 $0.00B $0.25B 0.42%
2011-03-31 $0.00B $0.26B 1.32%
2010-12-31 $-0.01B $0.22B -4.99%
2010-09-30 $0.01B $0.21B 4.32%
2010-06-30 $0.03B $0.22B 15.58%
2010-03-31 $0.03B $0.23B 19.76%
2009-12-31 $0.03B $0.17B 23.57%
2009-09-30 $0.02B $0.15B 14.15%
2009-06-30 $0.01B $0.12B 6.72%
2009-03-31 $0.01B $0.13B 5.09%
2008-12-31 $0.02B $0.14B 13.60%
2008-09-30 $0.02B $0.15B 15.27%
2008-06-30 $0.02B $0.13B 13.82%
2008-03-31 $0.02B $0.13B 13.55%
2007-12-31 $0.01B $0.13B 10.70%
2007-09-30 $0.02B $0.12B 19.21%
2007-06-30 $0.02B $0.11B 19.70%
2007-03-31 $0.02B $0.12B 18.22%
2006-12-31 $0.02B $0.13B 18.30%
2006-09-30 $0.01B $0.11B 11.66%
2006-06-30 $0.01B $0.11B 11.01%
2006-03-31 $0.01B $0.12B 13.40%
2005-12-31 $-0.01B $0.11B -8.74%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $3.726B $0.535B
Quidel Corp. discovers, develops, manufactures and markets point-of-care, rapid diagnostic tests for detection of medical conditions and illnesses. These products provide accurate, rapid and cost-effective diagnostic information for acute and chronic conditions that affect women's health throughout the phases of their lives including reproductive status, pregnancy management and osteoporosis. Quidel also provides point-of-care diagnostics for infectious diseases, including influenza A and B, strep throat, H. pylori infection, chlamydia and infectious mononucleosis.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $133.686B 23.40
Medtronic (MDT) Ireland $123.215B 16.57
Stryker (SYK) United States $61.179B 19.77
Boston Scientific (BSX) United States $43.868B 19.76
Baxter (BAX) United States $40.667B 24.82
Lonza Group Ag (LZAGY) Switzerland $30.356B 0.00
Coloplast (CLPBY) Denmark $29.419B 45.40
EssilorLuxottica Societe Anonyme (ESLOY) France $26.277B 0.00
Terumo (TRUMY) Japan $23.940B 29.88
ResMed (RMD) United States $21.189B 36.81
Zimmer Biomet Holdings (ZBH) United States $20.816B 12.81
Sunny Optical Technology (SNPTF) China $15.257B 0.00
Smith & Nephew SNATS (SNN) United Kingdom $15.108B 0.00
Insulet (PODD) United States $11.175B 683.73
Bio-Rad Laboratories (BIO) United States $10.212B 47.73
William Demant Holdings (WILYY) Denmark $7.898B 0.00
Hill-Rom Holdings (HRC) United States $6.846B 19.69
DiaSorin S.p.A (DSRLF) Italy $6.714B 0.00
Perrigo (PRGO) Ireland $6.335B 11.55
GN STORE NORD (GNNDY) Denmark $5.510B 28.47
Canopy Growth (CGC) Canada $5.296B 0.00
Haemonetics (HAE) United States $5.273B 32.46
Shandong Weigao Medical Polymer (SHWGF) China $5.020B 0.00
ICU Medical (ICUI) United States $3.803B 24.84
Neogen (NEOG) United States $3.131B 53.04
GW Pharmaceuticals (GWPH) United Kingdom $2.677B 0.00
NuVasive (NUVA) United States $2.614B 20.21
Agios Pharmaceuticals (AGIO) United States $2.586B 0.00
Hutchison China MediTech (HCM) Hong Kong, SAR China $2.532B 0.00
Envista Holdings (NVST) United States $2.464B 0.00
National Vision Holdings (EYE) United States $1.777B 29.93
Cardiovascular Systems (CSII) United States $1.219B 0.00
AtriCure (ATRC) United States $1.217B 0.00
TG Therapeutics (TGTX) United States $1.175B 0.00
Aurora Cannabis (ACB) Canada $1.058B 0.00
NanoString Technologies (NSTG) United States $0.993B 0.00
Aphria (APHA) $0.887B 0.00
VAREX IMAGING (VREX) United States $0.814B 16.91
Phibro Animal Health (PAHC) United States $0.810B 16.02
InMode (INMD) Israel $0.779B 0.00
Cerus (CERS) United States $0.707B 0.00
DFB Healthcare Acquisitions (AHCO) United States $0.628B 113.00
Omeros (OMER) United States $0.611B 0.00
PetIQ (PETQ) United States $0.605B 16.47
Eagle Pharmaceuticals (EGRX) United States $0.581B 34.52
OraSure Technologies (OSUR) United States $0.502B 62.23
Lantheus Holdings (LNTH) United States $0.501B 11.26
LeMaitre Vascular (LMAT) United States $0.489B 27.52
Surmodics (SRDX) United States $0.465B 53.42
Quanterix (QTRX) United States $0.459B 0.00
Zynex (ZYXI) United States $0.364B 39.64
Owens & Minor (OMI) United States $0.350B 9.57
Vapotherm (VAPO) United States $0.343B 0.00
Organigram Holdings (OGI) Canada $0.338B 0.00
Repro-Med Systems (KRMD) United States $0.318B 200.50
Utah Medical Products (UTMD) United States $0.305B 21.83
Meridian Bioscience (VIVO) United States $0.299B 12.02
MacroGenics (MGNX) United States $0.296B 0.00
HEXO (HEXO) $0.295B 0.00
Exagen (XGN) United States $0.219B 0.00
Cytosorbents (CTSO) United States $0.214B 0.00
Female Health (VERU) United States $0.209B 0.00
BioLife Solutions (BLFS) United States $0.206B 126.00
Rockwell Medical (RMTI) United States $0.169B 0.00
Viemed Healthcare (VMD) United States $0.163B 18.39
InfuSystems Holdings (INFU) United States $0.161B 135.33
Evolus (EOLS) United States $0.152B 0.00
United Health Products (UEEC) United States $0.146B 0.00
Bovie Medical (APYX) United States $0.135B 0.00
Neptune Wellness Solutions (NEPT) Canada $0.118B 0.00
Liberty Health Sciences (LHSIF) Canada $0.113B 0.00
Chimerix (CMRX) United States $0.093B 0.00
Chembio Diagnostics (CEMI) United States $0.092B 0.00
Fonar (FONR) United States $0.091B 6.64
Green Organic Dutchman Holdings (TGODF) Canada $0.078B 0.00
MTech Acquisition (KERN) United States $0.077B 0.00
Brainsway (BWAY) Israel $0.073B 0.00
United-Guardian (UG) United States $0.062B 13.08
Nephros (NEPH) United States $0.057B 0.00
Wound Management Technologies (SMTI) United States $0.054B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.054B 0.00
Surface Oncology (SURF) United States $0.051B 0.00
GUARDION HEALTH (GHSI) United States $0.033B 0.00
ImmuCell (ICCC) United States $0.033B 0.00
FSD PHARMA INC (HUGE) Canada $0.028B 0.00
NF Energy Saving (BIMI) China $0.023B 0.00
Trinity Biotech (TRIB) Ireland $0.019B 0.00
Myomo (MYO) United States $0.010B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.010B 0.00
Capricor Therapeutics (CAPR) United States $0.006B 0.00
Senestech (SNES) United States $0.004B 0.00
NeuroMetrix (NURO) United States $0.002B 0.00
Akers Biosciences Inc (AKER) United States $0.001B 0.00